Objective To evaluate 1 to 36 month follow-up outcomes of different endovascular treatment
strategies in above-the-knee (ATK) arterial segments in patients with intermittent …

Objectives To study the economic impact on payers and providers of the four main
endovascular strategies for the treatment of infrainguinal peripheral artery disease …

Purpose To compare the performance of drug-coated balloons (DCB) and drug-eluting
stents (DES) in long femoropopliteal lesions. Methods A retrospective dual center study …

This is a Standards of Practice document endorsed by CIRSE. The authors performed a
literature review and provide recommendations and quality improvement guidelines based …

Objectives This study was designed to evaluate the safety of a novel drug‐coated balloon
(DCB) with 2 µg/mm2 paclitaxel and a carrier comprised of polysorbate and sorbitol in a …

Purpose To determine the safety and efficacy of a new-generation nitinol stent with
enhanced flexibility in arterial lesions in the superficial femoral artery (SFA) and proximal …

Background Lower limb peripheral arterial disease (PAD) is a common, important
manifestation of systemic atherosclerosis. Stenoses or occlusions in the superficial femoral …

Endovascular intervention has become a well-recognized treatment modality for peripheral
artery disease; however, mid-and long-term outcomes have been plagued by limited …

Background Endovascular approach to superficial femoral artery (SFA) disease, the most
common cause of symptomatic peripheral arterial disease, remains fraught with high failure …

Polymerase-δ interacting protein 2 (Poldip2) is an understudied protein, originally described
as a binding partner of polymerase delta and proliferating cell nuclear antigen (PCNA) …